Mainz Biomed N.V (MYNZ) Equity Average: 2021-2025
Historic Equity Average for Mainz Biomed N.V (MYNZ) over the last 1 years, with Jun 2025 value amounting to $4.3 million.
- Mainz Biomed N.V's Equity Average rose 1063.37% to $4.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.3 million, marking a year-over-year increase of 1063.37%. This contributed to the annual value of $4.6 million for FY2024, which is 46.41% down from last year.
- As of Q2 2025, Mainz Biomed N.V's Equity Average stood at $4.3 million, which was up 349.14% from $953,922 recorded in Q4 2024.
- Over the past 5 years, Mainz Biomed N.V's Equity Average peaked at $11.9 million during Q1 2023, and registered a low of -$444,737 during Q2 2024.
- For the 3-year period, Mainz Biomed N.V's Equity Average averaged around $4.5 million, with its median value being $4.3 million (2025).
- Per our database at Business Quant, Mainz Biomed N.V's Equity Average slumped by 105.99% in 2024 and then surged by 1,063.37% in 2025.
- Mainz Biomed N.V's Equity Average (Quarterly) stood at $1.8 million in 2021, then reached $3.3 million in 2023, then crashed by 71.52% to $953,922 in 2024, then spiked by 1,063.37% to $4.3 million in 2025.
- Its last three reported values are $4.3 million in Q2 2025, $953,922 for Q4 2024, and -$444,737 during Q2 2024.